Stableford Capital Ii LLC Eli Lilly & CO Transaction History

Stableford Capital Ii LLC

$253 Million
Q3 2024

A detailed history of Stableford Capital Ii LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stableford Capital Ii LLC holds 9,828 shares of LLY stock, worth $7.65 Million. This represents 3.44% of its overall portfolio holdings.

Number of Shares

9,828

Previous 9,470 3.78%

Holding current value

$7.65 Million

Previous $8.57 Million 1.56%

% of portfolio

3.44%

Previous 3.34%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $276,426 - $343,687	358 Added 3.78%	9,828 $8.71 Million
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $114,529 - $143,628	-158 Reduced 1.64%	9,470 $8.57 Million
Q1 2024 Apr 09, 2024	BUY	$592.2 - $792.28 $376,047 - $503,097	635 Added 7.06%	9,628 $7.49 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $77,728 - $91,631	-148 Reduced 1.62%	8,993 $5.24 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $1.75 Million - $2.41 Million	-4,028 Reduced 30.59%	9,141 $4.91 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $4.62 Million - $6.18 Million	13,169 New	13,169 $6.18 Million
Q4 2022 Jan 10, 2023	SELL	$321.55 - $374.67 $49,518 - $57,699	-154 Reduced 1.13%	13,491 $4.72 Billion
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $7,708 - $8,784	-26 Reduced 0.19%	13,645 $4.65 Million
Q2 2022 Oct 25, 2022	BUY	$278.73 - $327.27 $7,246 - $8,509	26 Added 0.19%	13,671 $4.12 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $148,005 - $173,780	-531 Reduced 3.74%	13,671 $4.12 Million
Q1 2022 Apr 11, 2022	SELL	$234.69 - $291.66 $81,906 - $101,789	-349 Reduced 2.4%	14,202 $4.38 Million
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $287,808 - $357,171	1,280 Added 9.65%	14,551 $3.5 Million
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $456,939 - $562,328	2,062 Added 18.4%	13,271 $3.14 Million
Q1 2019 Feb 10, 2021	SELL	$111.31 - $131.02 $222 - $262	-2 Reduced 0.02%	11,209 $1.45 Million
Q1 2018 Feb 10, 2021	SELL	$74.21 - $87.6 $986,844 - $1.16 Million	-13,298 Reduced 54.26%	11,211 $867,000
Q4 2017 Feb 10, 2021	BUY	$81.94 - $87.89 $92,428 - $99,139	1,128 Added 4.82%	24,509 $2.07 Million
Q3 2017 Feb 10, 2021	BUY	$77.07 - $85.54 $28,438 - $31,564	369 Added 1.6%	23,381 $2 Million
Q2 2017 Feb 11, 2021	SELL	N/A	-369 Reduced 1.58%	23,012 $1.89 Million
Q2 2017 Feb 10, 2021	BUY	N/A	363 Added 1.58%	23,381 $2 Million
Q1 2017 Feb 10, 2021	BUY	N/A	11,110 Added 93.3%	23,018 $1.94 Million
Q4 2016 Feb 10, 2021	BUY	N/A	11,908	11,908 $876,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.

Account

Stableford Capital Ii LLC Eli Lilly & CO Transaction History